Advances in Prostaglandin and Leukotriene Research : Basic Science and New Clinical Applications (Medical Science Symposia Series)

個数:
  • ポイントキャンペーン

Advances in Prostaglandin and Leukotriene Research : Basic Science and New Clinical Applications (Medical Science Symposia Series)

  • ウェブストア価格 ¥32,770(本体¥29,791)
  • Springer(2010/12発売)
  • 外貨定価 US$ 169.00
  • ゴールデンウィーク ポイント2倍キャンペーン対象商品(5/6まで)
  • ポイント 594pt
  • 提携先の海外書籍取次会社に在庫がございます。通常3週間で発送いたします。
    重要ご説明事項
    1. 納期遅延や、ご入手不能となる場合が若干ございます。
    2. 複数冊ご注文の場合、分割発送となる場合がございます。
    3. 美品のご指定は承りかねます。
  • 【入荷遅延について】
    世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
    おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。
  • ◆画像の表紙や帯等は実物とは異なる場合があります。
  • ◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
    また、洋書販売価格は、ご注文確定時点での日本円価格となります。
    ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。
  • 製本 Paperback:紙装版/ペーパーバック版/ページ数 210 p.
  • 言語 ENG
  • 商品コード 9789048158812
  • DDC分類 572

Full Description

The 11th international Conference on ADVANCES IN PROSTAGLANDIN AND LEUKOTRIENE RESEARCH: BASICSCIENCEANDNEWCLlNICALApPLlCA TIONS was held, as in the past, in Florence, Italy, on June 4-8, 2000. A selection of lectures presented at the meeting is included in this volume, which continues the tradition of covering both basic and clinical aspects of prostaglandin and leukotriene research. At this meeting particular emphasis was given to the lipid mediator circuits of lipoxin and leukotrienes and to the expression ofthe COX2 gene. The plenary lectures by C.N. Serhan (Boston, Massachusetts, U.S.A.) and H.R. Herschman (Los Angeles, California, U.S.A.) were devoted to these areas, while S. Narumiya (Kyoto, Japan) and J.M. Drazen (Boston, Massachusetts, U.S.A.) presented the latest advances in the fields ofprostanoid receptors and the genetics of asthma. Specific sessions focused on vascular physiopathology, cell differentiation and cancer, and the cardiovascular system. Lipoxygenases were discussed in detail at the molecular and cellular levels and attention was given to signal transduction pathways for leukotrienes and prostanoids. K.F. Austen (Boston, Massachusetts, U.S.A.) and T.
Izumi (Tokyo, Japan) clarified the role and regulation ofLTC synthase ofleukotriene biosynthesis. Other important sessions 4 described regulation and control of nitric oxide, cannabimimetic eicosanoids, and the roles of eicosanoids in neuroscience. Applied clinical sessions devoted to the respiratory system and inflammation, including cyclooxygenase pathways, concluded the meeting.

Contents

I Lipdxygenases and Leukotriene Biosynthesis.- 1. Phosphorylation and Activation of 5-Lipoxygenase by P38 Kinase-Activated MAPKAP Kinases.- 2. 5-Lipoxygenase and the Nucleus: Where, When, How, and Why?.- 3. Calcium Binding Site of 5-Lipoxygenase.- 4. Regulation of Cellular 5-Lipoxygenase Activity by Glutathione Peroxidases.- 5. Novel Aspects Related to Biosynthesis and Biological Actions of Hepoxilins: Interrelationship with Phospholipid Hydro-Peroxide Glutathione Peroxidase (PHGPx).- 6. Transcriptional Regulation of the Human Leukotriene C4 Synthase Promoter.- 7. Localization and Translocation of Enzymes Involved in Leukotriene Biosynthesis.- II Cyclooxygenases and Prostaglandin Biosynthesis.- 8. Regulation of COX-2 Expression in Fibroblasts, Osteoblasts, Mast Cells, and Macrophages.- 9. Antimicroinflammatory Lipid Signals from Vascular Cyclooxygenase-2: A Novel Mechanism for NSAID and N-3 PUFA Therapeutic Actions.- 10. Substrate Interactions in the Cyclooxygenase-1 Active Site.- 11. Mutation of the Human Prostacyclin Synthase Gene.- 12. Structure and Function of Two Distinct Types of Prostaglandin D Synthase.- 13. Roles of Prostaglandin F Synthase.- 14. Differential Effects of Nitric Oxide on Cyclooxygenase 1 and 2 Activities in Cultured Cells.- III Phospholipase A2.- 15. On the Functional Diversity of Secreted Phospholipases A2: Cloning of Novel Mammalian and HIV-1 Antiviral Properties.- 16. Regulation of Cytosolic Phospholipase A2 by Phosphorylation.- IV Cytochrome P450 Archidonate Metabolites.- 17. Synthesis and Function of 20-Hydroxyeicosatetraenoic Acid in the Kidney.- V Receptors.- 18. Altered Bronchodilation and Pulmonary Inflammation in Prostanoid EP2 Receptor Knockout Mice.- 19. Induction of Prostaglandin I2 Receptor in Murine Osteoblastic Cell.- 20. BLT2, aSecond Leukotriene B4 Receptor.- 21. Upregulation of Cysteinyl-Leukotriene 1 Receptor Expression by Interleukin-5 in Human Leukocytes.- 22. Physiological and Pathophysiological Roles of Prostanoids; Lessons from Receptor-Knockout Mice for Clinical Applications.- 23. Multiple G-Protein Coupling of Chimeric Prostacyclin/Prostaglandin D2 Receptors.- VI Eicosanoids and Neuroscience.- 24. An Unusual Nicotinic Acetylcholine Receptor Activates the 8-Lipoxygenase Pathway in Aplysia Neurons.- VII Cardiovascular System.- 25. Neutrophil-Endothelial Cell Interaction: A Multidirectional Cross-Talk in Leukotriene Generation.- 26. Cyclooxygenase in the Lamb Ductus Arteriosus: Developmental Changes and Upregulation.- 27. Co-Localization of Prostacyclin (PGI2)-Synthase and Caveolin-1 in Endothelial Cells Underscores New Roles of PGI2 In Angiogenesis.- VIII Respiratory System.- 28. Leukotriene C4 Synthase Gene Polymorphism in Severe Asthma.- IX Inflammation.- 29. Anti-Inflammatory Levels of Aspirin and Salicylate Inhibit Integrin-Dependent Human Neutrophil Aggregation and PMN Influx in COX2- and NFkB(P105)- Knockout Mice.- 30. Antipyretic Action of Acetaminophen: Inhibition of the Cyclooxygenase Activity of Endothelial Cells Treated with IL-1.- 31. Leukotriene-Mediated Alteration of Endothelial Barrier Function.- 32. GI and Cardiovascular Profiles of New NSAIDs: Selective COX-2 Inhibitors and NO-NSAIDs.- 33. NO-Releasing NSAIDs Modulate Cytokine Secretion.- 34. Potent Inhibitory Effects of a NO-NSAID (Flurbiprofen Nitroxybutylester) on Bone Resorption in Vitro and in Vivo.- X Cancer.- 35. Lipid Peroxidation and Cyclooxygenase-2 Activity in Human Hepatocellular Carcinoma Cell Lines with and without Multiple Drug Resistance: Correlation with Cell Growth.- 36. Pulmonary Prostacyclin Synthase Overexpression Improves Survival Following Butylated Hydroxytoluene Exposure.- XI Isoprostanes.- 37. Reactive Products of the Isoprostane Pathway: Isoketals and Cyclopentenone A2/J2-Isoprostanes.- 38. Increased Isoprostane 8-epi-PGF2A in Statin-Induced Myopathy.